High Cut-off Hemodialysis Combined with Bortezomib-Based Therapy in Multiple Myeloma Patients with Severe Renal Impairment

被引：0
|
作者：
Baertsch, Marc-A. [1 ]
Raab, Marc S. [2 ]
Beimler, Joerg [3 ]
Meissner, Julia [3 ]
Schmier, Johann [3 ]
Goldschmidt, Hartmut [1 ]
Hillengass, Jens [1 ]
机构：
[1] Univ Hosp Heidelberg, Heidelberg, Baden Wurttembe, Germany
[2] Univ Clin Heidelberg, Dept Internal Med 5, Heidelberg, Germany
[3] Heidelberg Univ, Heidelberg, Germany
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2017年 / 17卷 / 01期
关键词：
D O I：
10.1016/j.clml.2017.03.218
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PS-216
引用
收藏
页码：E120 / E120
页数：1
相关论文
共 50 条
  • [21] EXTENDED CITRATE HIGH CUT-OFF HEMODIALYSIS FOR the TREATMENT OF MYELOMA PATIENTS WITH DIALYSIS-DEPENDENT RENAL FAILURE
    Pernat, A. Marn
    Kovac, J.
    Gubensek, J.
    Ponikvar, R.
    Buturovic-Ponikvar, J.
    [J]. INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2010, 33 (07): : 422 - 422
  • [22] Bortezomib-based treatment for multiple myeloma patients with renal impairment A systematic review and meta-analysis of observational studies
    Zhu, Wangiu
    Chen, Wenming
    [J]. MEDICINE, 2016, 95 (46)
  • [23] EFFICIENCY OF THERAPY HEMODIALYSIS PATIENTS WITH MULTIPLE MYELOMA AND RENAL FAILURE BY BORTEZOMIB PROTOCOLS
    Mitina, T. A.
    Golenkov, A. K.
    Lutskaya, T. D.
    Kataeva, E. V.
    Trifonova, E. V.
    Dudina, G. A.
    Buravtsova, I. V.
    Vysot-Skaya, L. L.
    Prokopenko, E. I.
    Fomin, A. M.
    Suslov, V. P.
    Vatazin, A. V.
    [J]. GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2011, 56 (04): : 12 - 16
  • [24] Combined immune score predicts the prognosis of newly diagnosed multiple myeloma patients in the bortezomib-based therapy era
    Wei, Min
    Guo, Honggang
    Liu, Siwei
    Xu, Fangfang
    Zhang, Yin
    Shi, Jie
    Xu, Zhiwei
    Chen, Yuqing
    [J]. MEDICINE, 2021, 100 (41) : E27521
  • [25] EFFECTS OF BORTEZOMIB ON RENAL IMPAIRMENT MULTIPLE MYELOMA PATIENTS
    Chen, W.
    Lu, J.
    Hou, J.
    [J]. HAEMATOLOGICA, 2013, 98 : 340 - 341
  • [26] An International Study of High Cut-off Hemodialysis for the Management of Myeloma Kidney
    Hutchison, Colin A.
    Bevins, Anne
    Mead, Graham
    Cook, Mark
    [J]. BLOOD, 2011, 118 (21) : 1700 - 1701
  • [27] Results of the first bortezomib-based induction therapy in the treatment of multiple myeloma
    Kortuem, Martin
    Einsele, Hermann
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (10) : 1661 - 1663
  • [28] Impact of bortezomib-based versus lenalidomide maintenance therapy on outcomes of patients with high-risk multiple myeloma
    Bumma, Naresh
    Dhakal, Binod
    Fraser, Raphael
    Estrada-Merly, Noel
    Anderson, Kenneth
    Freytes, Cesar O.
    Hildebrandt, Gerhard C.
    Holmberg, Leona
    Krem, Maxwell M.
    Lee, Cindy
    Lekakis, Lazaros
    Lazarus, Hillard M.
    Mian, Hira
    Murthy, Hemant S.
    Nathan, Sunita
    Nishihori, Taiga
    Parrondo, Ricardo
    Patel, Sagar S.
    Solh, Melhem
    Strouse, Christopher
    Vesole, David H.
    Kumar, Shaji
    Qazilbash, Muzaffar H.
    Shah, Nina
    D'Souza, Anita
    Sidana, Surbhi
    [J]. CANCER, 2023, 129 (14) : 2179 - 2191
  • [29] Haemodialysis using high cut-off dialysers for treating acute renal failure in multiple myeloma
    Martin-Reyes, Guillermo
    Toledo-Rojas, Remedios
    Torres-Rueda, Alvaro
    Sola-Moyano, Eugenia
    Blanca-Martos, Lourdes
    Fuentes-Sanchez, Laura
    Dolores Martinez-Esteban, M.
    Jose Diez-de los Rios, M.
    Bailen-Garcia, Alicia
    Gonzalez-Molina, Miguel
    Garcia-Gonzalez, Isabel
    [J]. NEFROLOGIA, 2012, 32 (01): : 35 - 43
  • [30] Pharmacokinetics of lenalidomide during high cut-off dialysis in a patient with multiple myeloma and renal failure
    Kim Dao
    Yimin Lu
    Cody J. Peer
    William D. Figg
    Raphael Stadelmann
    Michel Burnier
    Thierry Buclin
    Sebastien Kissling
    [J]. Cancer Chemotherapy and Pharmacology, 2017, 79 : 215 - 218
12345